TM: why is it so important
In the EU alone, losses from counterfeit medicines exceed 10 billion euros per year. Therefore, manufacturers are blowing on the water, seeing threats to their investments everywhere. Recently, the British pharmacist GlaxoSmithKline (GSK) lost the case of a small company Apollo Generics. The manufacturer of generics decided to register the trademark ZANAMOL. GSK was afraid that she messed up with a known drug PANADOL.